A Phase 1, Blinded, Randomized, Placebo Controlled, Parallel-Group, Single-Dose, Dose-Escalation Study to Investigate Safety, Tolerability, and Pharmacokinetics of Emodepside (BAY 44-4400) After Oral Dosing in Healthy Male Subjects

Trial Profile

A Phase 1, Blinded, Randomized, Placebo Controlled, Parallel-Group, Single-Dose, Dose-Escalation Study to Investigate Safety, Tolerability, and Pharmacokinetics of Emodepside (BAY 44-4400) After Oral Dosing in Healthy Male Subjects

Recruiting
Phase of Trial: Phase I

Latest Information Update: 06 Feb 2017

At a glance

  • Drugs Emodepside (Primary)
  • Indications Onchocerciasis
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 31 Jan 2017 Planned End Date changed from 1 Nov 2016 to 1 Mar 2017.
    • 31 Jan 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Mar 2017.
    • 21 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top